$70.62
+1.41 (+2.04%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
-4.77%
1Y
+40.23%
YTD
-7.97%
Open$68.99
Previous Close$69.21
Day High$71.04
Day Low$68.99
52W High$90.87
52W Low$43.18
Volume—
Avg Volume1.09M
Market Cap5.85B
P/E Ratio792.55
EPS$4.49
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$75.08
Below
SMA 200
$61.55
Above
RSI (14)
25.1
Oversold
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
21 analysts
Price Target
+10.4% upside
Current
$70.62
$70.62
Target
$77.98
$77.98
$54.55
$77.98 avg
$125.35
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.69B | 1.17B | 623.61M |
| Net Income | 665.43M | 414.48M | 103.27M |
| Profit Margin | 39.4% | 37.5% | 16.6% |
| EBITDA | 869.19M | 571.47M | 195.81M |
| Free Cash Flow | — | — | 61.49M |
| Rev Growth | +128.3% | +35.3% | +11.8% |
| Debt/Equity | 0.51 | 848.93 | 0.18 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $245.22 | +0.55% | 122.9 | 446.67B |
| AMGN | Amgen Inc | $407.95 | +0.77% | 26.5 | 206.48B |
| GILD | Gilead Sciences Inc | $133.75 | +2.21% | 17.6 | 161.72B |
| VRTX | Vertex Pharmaceuticals Inc | $484.53 | -0.06% | 27.8 | 120.52B |
| REGN | Regeneron Pharmaceuticals | $782.10 | +1.29% | 17.5 | 77.36B |
| ALNY | Alnylam Pharmaceuticals Inc | $217.68 | +0.72% | 47.7 | 27.52B |